Gritstone bio, Inc. revenue breakdown overview

Gritstone bio, Inc. revenue for the last year amounted to 16.34 M USD, the most of which — 16.34 M USD — came from its highest performing source at the moment, Vaccine-based Immunotherapy, the year earlier bringing 19.95 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Gritstone bio, Inc. 16.34 M USD, and the year before that — 19.95 M USD.